napolis, Ind.) was coupled to poly-L-lysine by the method of Gray (6). Briefly, 0.1 ml (1,000 ,ug/ml) of a solution of PRP in deionized water was added to 0.5 ml of 0.01 N NaOH with 0.001% phenolphthalein indicator. After alkalinization of the PRP, the solution was added to 0.5 mg of cyanuric chloride (Sigma Chemical Co., St. Louis, Mo.) and mixed for 10 s. This mixture was added to 0.1 ml of 0.1% poly-L-lysine (type VII-B; Sigma Chemical Co.), mixed, and refrigerated at 4°C for 2 h. A control poly-L-lysine solution was prepared in an identical fashion except deionized water without PRP was used. After 2 h, the PRP solution was diluted in Dulbecco phosphate-buffered saline (PBS) without calcium or magnesium (GIBCO Laboratories, Grand Island, N.Y.) to obtain a PRP concentration of 1 ,ug/ml. The control poly-L-lysine solution was diluted similarly. Alternate columns of round-bottomed microtiter well substrate plates (Immulon AUS-coated; Dynatech Laboratories, Inc., Alexandria, Va.) were filled with 200 p.l of either PRP-poly-L-lysine or control poly-L-lysine per well. The plates were stored at 4°C without washing until used. Plates could be stored in this manner for at least 3 months, and there was excellent reproducibility of serum titers (within one to two dilutions) from batch to batch of PRP-poly-Llysine-coated plates.
The enzyme-linked immunosorbent assay (ELISA) technique has been used to determine concentrations of antibody directed against the capsular polysaccharides of Streptococcus pneumoniae and Haemophilus influenzae type b (1, 3, 4, 9, 11, 13) . ELISA offers a rapid, relatively inexpensive method to quantitate and differentiate immunoglobulins to capsular polysaccharide. We describe an ELISA method for detecting antibody directed against the polyribosephosphate (PRP) capsule of H. influenzae type b and compare ELISA results with those obtained by radioimmunoassay (RIA). This ELISA method can be established in most laboratories and may be potentially important should an effective vaccine directed against the PRP of H. influenzae type b become available for young children. MATERIALS napolis, Ind.) was coupled to poly-L-lysine by the method of Gray (6) . Briefly, 0.1 ml (1,000 ,ug/ml) of a solution of PRP in deionized water was added to 0.5 ml of 0.01 N NaOH with 0.001% phenolphthalein indicator. After alkalinization of the PRP, the solution was added to 0.5 mg of cyanuric chloride (Sigma Chemical Co., St. Louis, Mo.) and mixed for 10 s. This mixture was added to 0.1 ml of 0.1% poly-L-lysine (type VII-B; Sigma Chemical Co.), mixed, and refrigerated at 4°C for 2 h. A control poly-L-lysine solution was prepared in an identical fashion except deionized water without PRP was used. After 2 h, the PRP solution was diluted in Dulbecco phosphate-buffered saline (PBS) without calcium or magnesium (GIBCO Laboratories, Grand Island, N.Y.) to obtain a PRP concentration of 1 ,ug/ml. The control poly-L-lysine solution was diluted similarly. Alternate columns of round-bottomed microtiter well substrate plates (Immulon AUS-coated; Dynatech Laboratories, Inc., Alexandria, Va.) were filled with 200 p.l of either PRP-poly-L-lysine or control poly-L-lysine per well. The plates were stored at 4°C without washing until used. Plates could be stored in this manner for at least 3 months, and there was excellent reproducibility of serum titers (within one to two dilutions) from batch to batch of PRP-poly-Llysine-coated plates.
ELISA procedure. The ELISA procedure was modified from that of Barrett et considered positive if all three of the triplicate samples in the PRP-poly-L-lysine-coated wells exceeded the mean plus three standard deviations of the triplicate samples of the same dilution in the corresponding poly-L-lysine control-coated wells (2, 10) .
Anti-PRP antibodies were determined by RIA in the laboratory of J.C.P. (12) . A 125I-labeled derivative of H. influenzae type b polysaccharide was prepared by a modification of the method of Gotschlich et al. (5) . H. influenzae polysaccharide (5 mg/ml) was brought to pH 10.5 with 0.1 M sodium hydroxide. Cyanogen bromide (100 mg/ml) at 0.3 mg/mg of polysaccharide was added, and the pH was maintained at 10.5 with 0.1 M sodium hydroxide for 6 min at 4°C. Tyramine (50 mg/ml) and 0.5 M sodium bicarbonate in equal weight to the polysaccharide were added. (The pH of the mixture was 8.5 .) The mixture was tumbled at 4°C for 16 h, centrifuged, and passed through a Sephadex G-25 column in PBS. This product was radiolabeled with 2 mCi of 1251 by the chloramine-T method (8) .
An 2-ME inactivation. The ELISA IgG and IgM anti-PRP antibody titers for sera from six healthy adults before and after 2-ME inactivation are shown in Table 1 . There were no differences in the IgG titers, but the IgM titers were significantly reduced (t = 8.37, P < 0.001) after 2-ME inactivation of sera.
ELISA and RIA anti-PRP antibody determinations. The IgG and IgM anti-PRP antibody titers by ELISA are compared with anti-PRP antibody concentrations by RIA in sera from 29 children with H. influenzae type b infections in Table 2 .
Children with nondetectable anti-PRP antibody by RIA generally had no detectable titers (<1:4 or <1:8) by ELISA also (except for three patients). The sum of the log IgG and log IgM titers correlated significantly (r = 0.640, P < 0.001) with the total anti-PRP antibody content by RIA. Early and late serum samples were available in 13 children. In all instances, there was complete agreement between ELISA and RIA in determining whether an antibody response had occurred. Patients 17 and 24 were of particular interest. Both children initially had anti-PRP antibodies that were predominately of the IgM class but that on follow-up were predominately of the IgG class. 
